Alzheimer's Disease Treatment Cost in India

Find the best Alzheimer's Disease Treatment cost in India. Compare top hospitals, success rates and patient reviews.

Starting From

$500

Average Cost

$2,000

Up To

$6,000

What Is the Cost of Alzheimer's Disease in India?

Alzheimer's Disease treatment in India typically ranges from $500 to $6,000 USD, depending on the hospital, city, and type of procedure.

Key Factors That Influence the Cost

  • Type of Surgery: Multimodal cholinesterase inhibitor regimens versus targeted anti-amyloid monoclonal antibody infusions.
  • Location and Facility: Tier-1 private hospitals in major medical hubs like Delhi NCR, Mumbai, or Bengaluru generally charge higher rates than regional or specialized centers.
  • Hospital Stay: Length of time required in the Intensive Care Unit (ICU) and post-operative monitoring (Outpatient diagnostic assessment protocol with 1-day observation for infusion starts).
  • Pre- and Post-Op Care: Diagnostic imaging (Volumetric 3T Brain MRI, Amyloid/Tau PET imaging, CSF biomarker testing (Abeta42/Tau), and neuropsychological battery), medication, and follow-up consultations.
  • Implants and Consumables: Infusion port systems for bi-weekly monoclonal therapies and cognitive tracking software.

Note: Final quotations must be confirmed with the hospital following a comprehensive review of your medical records.

Alzheimer's Disease Cost Comparison Across Different Cities in India

Treatment costs for Alzheimer's Disease remain highly competitive across India's premier medical hubs, including Delhi NCR, Mumbai, Chennai, Bengaluru, and Hyderabad.

Geographical cost variations between hospitals are driven by specific institutional and operational standards:

  • Hospital Accreditation: Tertiary and quaternary hospitals accredited by JCI and NABH maintain specialized infrastructure including dedicated operating theaters and intensive care units.
  • Surgeon & Specialist Standing: Senior Cognitive Neurologists and Geriatric Specialists with high procedural volume and international training.
  • Technological Capabilities: Centers equipped with advanced diagnostic and surgical systems such as Infusion port systems for bi-weekly monoclonal therapies and cognitive tracking software.
  • Local Living & Caregiver Expenses: Daily accommodation, transport, and food costs in metropolitan cities (higher in Mumbai and Delhi than in Chennai or Hyderabad).

Patients are advised to prioritize hospital accreditation and specialist expertise over minor cost differences between cities.

Our Services for Alzheimer's Disease Treatment in India

Transparent, professional support—without the hassles.

Book Doctor Appointment

Choose a specialist and schedule a convenient consultation.

Video or In-person Consultation

Consult remotely or meet your doctor directly at the hospital.

Compare Cost Estimates

Review transparent estimates from suitable hospitals.

Hospitalisation Support

Get coordinated assistance throughout your hospital stay.

WhatsApp Us

What Factors Affect the Cost of a Alzheimer's Disease?

The overall cost of managing Alzheimer's Disease in India varies according to patient-specific clinical requirements and procedural scope.

Key variables directly influencing the final treatment expenditure include:

  • Primary Clinical Approach: Multimodal medical stabilization (cholinesterase inhibitors, memantine), cognitive rehabilitation, and anti-amyloid therapies.
  • Pre-Treatment Staging & Investigations: Volumetric 3T Brain MRI, Amyloid/Tau PET imaging, CSF biomarker testing (Abeta42/Tau), and neuropsychological battery.
  • Surgical Implants & Technology: Use of specialized devices such as Infusion port systems for bi-weekly monoclonal therapies and cognitive tracking software.
  • Hospitalization Duration: Length of time in the ICU and room selection (twin sharing vs. private single room).
  • Complication Risk Management: Potential clinical events requiring intervention, including Amyloid-related imaging abnormalities (ARIA), gastrointestinal disturbances from medications, and anxiety.
  • Post-Procedure Rehabilitation: Ongoing chronic supportive care with 3- to 6-month clinical reviews.

Hospitals provide an itemized fee breakdown following a thorough review of the patient's diagnostic imaging and medical dossier.

Why Choose India for Alzheimer's Disease Treatment?

India is a preferred destination for international patients seeking advanced, affordable clinical management for Alzheimer's Disease.

Key reasons to choose India for treatment include:

  • Expert Medical Specialists: Board-certified Cognitive Neurologists and Geriatric Specialists with international fellowships and proven track records.
  • Internationally Accredited Hospitals: Facilities certified by JCI and NABH upholding strict safety, hygiene, and patient-care protocols.
  • State-of-the-Art Technology: Immediate access to advanced platforms including Infusion port systems for bi-weekly monoclonal therapies and cognitive tracking software.
  • Substantial Cost Savings: Treatment delivered at 60% to 80% lower cost compared to the United States, UK, or private Middle Eastern centers.
  • Dedicated International Concierge: End-to-end support with medical visa invitation letters, language translators, airport pickups, and local stay arrangements.
  • Zero Waiting Times: Fast-track specialist consultations, immediate diagnostic workups, and prompt procedural scheduling.

Note: Individual treatment candidacy and anticipated outcomes must be confirmed directly through a specialist clinical evaluation.

Top Doctors in India

Recommended Doctors for Alzheimer's Disease Treatment

Top Hospitals in India

Recommended Hospitals for Alzheimer's Disease Treatment

Frequently Asked Questions Related to Alzheimer's Disease Treatment Cost in India

Alzheimer's Disease is a medical condition treated in India through tailored interventions led by Cognitive Neurologists and Geriatric Specialists.

Main treatment approaches include:

  • Cholinesterase Inhibitor Therapy: Medications (Donepezil, Rivastigmine) to support neurotransmission and memory function.
  • Anti-Amyloid Monoclonal Antibodies: Targeted infusions designed to slow cognitive decline in mild cognitive impairment stages.
  • Cognitive & Behavioral Therapy: Structured memory adaptation, occupational therapy, and caregiver guidance programs.

Need Assistance?Chat